semaglutide fda label warns about safety of 'off-brand' versions of Ozempic, Wegovy FDA Warns on Certain Forms

Hepatic Impairment The effect of hepatic impairment on the pharmacokinetics of insulin glargine products has not been studied

The GLP-1 analog liraglutide, a modified human GLP-1(737) with a longer half-life 29 , is administered systemically in patients with type II diabetes (commercial name Victoza ) and obesity (commercial name Saxenda )

They can advise when to take your medications, dietary considerations, and potential food-drug interactions that should be avoided

Adam Evans, MD, a reproductive endocrinology and infertility specialist at University Hospitals, shares more about these possibilities to help people make informed, confident decisions about their fertility plans and how they may intersect with their weight loss goals